| Drug Name: | Rifaximin (80621-81-4) |
|---|---|
| PubChem ID: | 122361733 |
| SMILES: | C[C@H]1/C=C/C=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(OC=C[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C |
| InchiKey: | NZCRJKRKKOLAOJ-OUVHNKGRSA-N |
| Therapeutic Category: | Anti-Infective Agents, Gastrointestinal Agents |
| Molecular Weight (dalton) | : | 785.891 |
| LogP | : | 6.15784 |
| Ring Count | : | 4 |
| Hydrogen Bond Acceptor Count | : | 13 |
| Hydrogen Bond Donor Count | : | 5 |
| Total Polar Surface Area | : | 198.38 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category